Wednesday, August 26, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Optimistic Normal choppiness · VIX 15.5
Breadth is unusually strong, with dozens of S&P 500 names posting large one-day gains alongside sustained 5- and 30-day uptrends and many trading within 1-3% of their 52-week highs, consistent with a strong earnings season. Diagnostics/healthcare, payments, and select commodity names (gold, copper) show the most durable multi-timeframe momentum, while hotter-than-expected inflation data and commentary urging profit-taking in AI/momentum names argue for selectivity rather than chasing the most extended movers.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | MRK | SKIP | — | $154.88 → $162.78 stop $142.64 |
Position cap reached — 100 of 20 slots in use. |
| #2 | CRL | SKIP | — | $298.40 → $313.69 stop $272.44 |
Position cap reached — 100 of 20 slots in use. |
| #3 | IBKR | SKIP | — | $96.25 → $101.06 stop $88.16 |
Position cap reached — 100 of 20 slots in use. |
| #4 | NEM | SKIP | — | $132.76 → $139.62 stop $120.94 |
Position cap reached — 100 of 20 slots in use. |
| #5 | AJG | SKIP | — | $268.90 → $282.34 stop $249.27 |
Position cap reached — 100 of 20 slots in use. |
Already open: JPM (to Aug 26), CB (to Aug 27), JPM (to Aug 27), RTX (to Aug 27), WAB (to Aug 27), DGX (to Aug 28), HIG (to Aug 28), WAB (to Aug 28), GM (to Aug 29), MET (to Aug 30), AMP (to Sep 3), MSFT (to Sep 4) … and 88 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
Merck is a major pharmaceutical company known for its cancer drug Keytruda and a broad portfolio of medicines. The company just reported higher sales and raised its full-year profit and revenue targets, a strong sign of underlying business momentum. The main risk is that a one-time accounting charge from a recent acquisition makes headline profit look weak, and several company insiders have been selling shares.
Why the AI likes it
What could go wrong
Calibrated probability: 70% (raw model estimate: 64%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Charles River Labs runs drug-testing and research services that pharmaceutical companies rely on to develop new medicines. It beat expectations and raised its full-year outlook thanks to strengthening client demand, but the stock has already climbed over 30% in the past month and looks stretched, with several company insiders (including the CEO) selling shares recently. The main risk is that this rally has already priced in most of the good news, making a pullback more likely.
Why the AI likes it
What could go wrong
Calibrated probability: 70% (raw model estimate: 64%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Interactive Brokers operates a popular online trading platform for stocks, options, and other investments. Its shares are showing balanced, healthy momentum while trading above key moving averages, a favorable technical setup, and a company director has recently been buying shares. The main risk is that the stock is barely beating the broader market right now, so its edge over an ordinary market rally is thin.
Why the AI likes it
What could go wrong
Calibrated probability: 70% (raw model estimate: 63%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Newmont is the world's largest gold mining company. Gold-related stocks are currently one of the strongest-performing corners of the market, and Newmont's share price has surged well ahead of the broader market over the past month. The main risk is that after such a fast run-up, the stock is very overbought and could see a sharp pullback if gold prices cool off.
Why the AI likes it
What could go wrong
Calibrated probability: 70% (raw model estimate: 64%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Arthur J. Gallagher is a large insurance brokerage that helps businesses and individuals arrange insurance coverage. Its stock shows healthy upward momentum and trades above its key moving averages, a bullish technical setup, even though shares remain well below their 52-week high. The main risk is that this gap to the high suggests some past weakness that could resurface, on top of the usual risk that any rally can fade.
Why the AI likes it
What could go wrong
Calibrated probability: 70% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by September 25, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 503 S&P 500 constituents and short-listed 27 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.